Epic Sciences

Epic Sciences is a San Diego, California clinical diagnostics company founded in 2008 that develops blood-based "liquid biopsy" tests for oncology. Its platform, licensed from the Peter Kuhn laboratory at Scripps Research, isolates and characterizes rare circulating tumor cells (CTCs) from whole blood using specialized assays and digital pathology algorithms, and is paired with circulating tumor DNA (ctDNA) sequencing to inform treatment selection and track how a tumor evolves. Its lead product, DefineMBC, is a comprehensive blood biopsy for metastatic breast cancer whose 56-gene ctDNA panel received Medicare coverage in April 2023. The company also runs its platform as a service for pharmaceutical partners measuring outcomes in clinical trials, and in 2020 partnered with Predicine to combine CTC and ctDNA analysis in a single offering. Epic Sciences is privately held and has raised roughly $204M across seven rounds through a Series G in April 2023. It is a laboratory diagnostics provider, not a software vendor, and publishes no public API, developer program, SDK or machine-readable specification.

Epic Sciences is profiled on the APIs.io network. Tagged areas include Company, Health Care, Diagnostics, Oncology, and Life Sciences.

🌐 Visit website 📡 Source on GitHub
5.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyHealth CareDiagnosticsOncologyLife SciencesBiotechnologyLaboratoryPrecision Medicine

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 5.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/epic-sciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Epic Sciences Domain Security

TLSv1.3

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: epic-sciences
name: Epic Sciences
description: Epic Sciences is a San Diego, California clinical diagnostics company founded in 2008 that develops blood-based
  "liquid biopsy" tests for oncology. Its platform, licensed from the Peter Kuhn laboratory at Scripps Research, isolates
  and characterizes rare circulating tumor cells (CTCs) from whole blood using specialized assays and digital pathology algorithms,
  and is paired with circulating tumor DNA (ctDNA) sequencing to inform treatment selection and track how a tumor evolves.
  Its lead product, DefineMBC, is a comprehensive blood biopsy for metastatic breast cancer whose 56-gene ctDNA panel received
  Medicare coverage in April 2023. The company also runs its platform as a service for pharmaceutical partners measuring outcomes
  in clinical trials, and in 2020 partnered with Predicine to combine CTC and ctDNA analysis in a single offering. Epic Sciences
  is privately held and has raised roughly $204M across seven rounds through a Series G in April 2023. It is a laboratory
  diagnostics provider, not a software vendor, and publishes no public API, developer program, SDK or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/epic-sciences/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Health Care
- Diagnostics
- Oncology
- Life Sciences
- Biotechnology
- Laboratory
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/epic-sciences-domain-security.yml
- type: Website
  url: https://forgeglobal.com/epic-sciences_stock/
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: epicsciences.com — the site every third-party record still lists as the company website — serves a blanket HTTP
    301 to an unrelated third-party domain (awaji-musicisland.com) on every path including /robots.txt and every /.well-known/
    location, and the domain publishes no MX, SPF, DMARC, CAA or DNSSEC records, so there is no live Epic Sciences web presence
    left to profile, let alone a developer surface.
  evidence:
  - url: https://www.epicsciences.com/
    status: 301
  - url: https://www.epicsciences.com/.well-known/agent-card.json
    status: 301
  - url: https://www.epicsciences.com/openapi.json
    status: 301
  - url: https://api.github.com/orgs/epic-sciences
    status: 404
  checked: '2026-08-12'